APPLICATION
BLA103608
TYPE
BLA
ORIGINAL APPROVAL
1996-10-28
LATEST ACTION
2012-06-26
ROUTE
INTRAVENOUS
DOSAGE FORM
VIAL
MARKETING STATUS
Prescription
Products
PROSTASCINTPrescription
CAPROMAB PENDETIDE 05.MG/ML · VIAL · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.